SELUTION DeNovo Trial Results The SELUTION DeNovo randomized clinical trial, presented at TCT 2025 in San Francisco, USA, demonstrated non-inferiority of a drug-eluting balloon to standard…
Materialise: Q3 Earnings Snapshot Materialise NV (MTLS) reported earnings of $2.2 million in its third quarter. The company, based …
The Betami-Danblock Trial The BETAMI-DANBLOCK trial evaluates the safety of discontinuing beta-blockers after myocardial infarction (MI) i…
Cygnet Energy to Acquire Kiwetinohk Privately held Cygnet Energy will acquire Kiwetinohk Energy in an all-cash deal valued at C$1.4 billio…
Giving States Waivers From Accountability Is a Dangerous Step Backward for Kids By loosening testing and reporting requirements, the Educa…
Honkarakenne Brings Finnish Timber Construction Expertise to Kazakhstan Honkarakenne, a global leader in CLT log construction, has signed …
TCT 2025: STORM-PE Trial Demonstrates Safety and Efficacy of Mechanical Thrombectomy in Intermediate-High-Risk Pulmonary Embolism This new…
Cygnet Energy Enters into Agreement to Acquire Kiwetinohk Energy Corp. Cygnet Energy Ltd., a private exploration and production company, h…
Building the Future, Respecting the Past Tbilisi is undergoing a dynamic transformation, with sustainable urban development taking center …
ServiceNow and Nvidia Introduce Apriel 2.0 for Enhanced Security ServiceNow and Nvidia have launched Apriel 2.0, an open-source AI model d…
Grokipedia Launch and Controversy Elon Musk's Grokipedia, a rival to Wikipedia, has launched after a brief crash. The website, which claim…